Vendors and users of healthcare information technology must work together to shore up their defenses, according to representatives of the medical devices business.
Vendors and users of healthcare information technology must work together to shore up their defenses, according to representatives of the medical devices business.
A new white paper offers an explanation of software threats, outlines potential vulnerabilities, and suggests practical defense strategies. The document was produced by a trade-based international security and privacy committee with representatives from the National Electrical Manufacturers Association, European Coordination Committee of the Radiological and Electromedical Industry, and Japanese Industries Association of Radiological Systems. It can be downloaded at www.nema.org.
Technical solutions to security breaches include checksum calculations and system profiles that can verify the integrity of entire directories. Virus scanning software can itself cause problems when used on medical IT equipment, as software may mistakenly try to "fix" normal image data or shut down an entire system on the basis of a false alert.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.